论文部分内容阅读
目的:探讨老年2型糖尿病骨密度检测的临床应用价值。方法:选择2012年7月~2013年7月我院门诊40例老年健康体检者作为对照组,同期选择40例老年2型糖尿病患者作为糖尿病组,2组都进行左侧股骨骨密度测定,同时进行骨质疏松判断。结果:糖尿病患者的左侧股骨3个部位的骨密度值都明显少于对照组,差异有统计学意义(P<0.05)。糖尿病组骨质疏松发病率为47.5%,对照组的骨质疏松发病率是15.0%,2组对比差异明显(P<0.05)。结论:老年2型糖尿病骨密度值都相对少,同时多伴随有骨质疏松,因此其临床检测价值大。
Objective: To investigate the clinical value of measuring bone mineral density in senile type 2 diabetes mellitus. Methods: From July 2012 to July 2013, 40 elderly health examination subjects in our hospital were selected as the control group. Forty elderly patients with type 2 diabetes mellitus were selected as the diabetes mellitus group. The left femur bone mineral density was measured in both groups at the same time Osteoporosis judge. Results: The bone mineral density in the three parts of the left femur of diabetic patients were significantly less than that of the control group, the difference was statistically significant (P <0.05). The incidence of osteoporosis in diabetic group was 47.5%, and the incidence of osteoporosis in control group was 15.0%. The difference between the two groups was significant (P <0.05). CONCLUSION: The bone mineral density in type 2 diabetes is relatively low in elderly patients with osteoporosis. Therefore, its clinical value is high.